TheraRadar
← Back
Data updated: Mar 29, 2026

CIPHER

OncologyGastroenterology
Pharma

CIPHER is a pharmaceutical company focused on Oncology, Gastroenterology.

2011
Since
1
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

NATROBA
spinosad
2 indications · 2011

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 65%
0 drugs Phase 3: 3 Phase 1: 10
Gastroenterology 35%
0 drugs Phase 3: 2 Phase 1: 4

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Gastroenterology
Bristol-Myers Squibb big-pharma
Oncology, Gastroenterology
Takeda big-pharma
Oncology, Gastroenterology
Gilead Sciences biotech
Oncology, Gastroenterology
ASTELLAS specialty
Oncology, Gastroenterology